Multiple myeloma
Л. П. Менделеева(National Research Center for Hematology Russian Academy of Medical Sciences), Tigran G. Gevorkian(Kementerian Kesehatan Republik Indonesia), И Г Рехтина, I V Poddubnaya(Saratov State University), Zhanna V. Khailova(Medical Radiological Research Center), А. М. Ковригина(Shupyk National Healthcare University of Ukraine), Evgenii A. Osmanov(Sechenov University), В В Байков(First Pavlov State Medical University of St. Petersburg), С. А. Иванов(Ministry of Health of the Russian Federation), О М Вотякова(Kementerian Kesehatan Republik Indonesia), Н. А. Фалалеева(Medical Radiological Research Center), Aleksei A. Nevol’skikh(Medical Radiological Research Center), Л. Ю. Гривцова(Medical Radiological Research Center)
Cited by 30
Related Papers
Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation
|Bone Marrow Transplantation|2014|195
Atlas of RNA sequencing profiles for normal human tissues
|Scientific Data|2019|142
Current Multiple Myeloma Treatment Strategies with Novel Agents: A European Perspective
|The Oncologist|2010|92
Nuclear nanomedicine using Si nanoparticles as safe and effective carriers of 188Re radionuclide for cancer therapy
|Scientific Reports|2019|67
Thromboelastography, thrombin generation test and thrombodynamics reveal hypercoagulability in patients with multiple myeloma
|Leukemia & lymphoma/Leukemia and lymphoma|2015|59